Published in Rheumatology (Oxford) on July 16, 2003
B-cell activity in children with malaria. Malar J (2012) 0.85
Serum levels of soluble CD21 in patients with systemic sclerosis. Rheumatol Int (2010) 0.78
Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis. Rheumatol Int (2011) 0.77
Soluble CD21 in sera and synovial fluid of arthritic patients. Rheumatol Int (2005) 0.76
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells. Transl Neurodegener (2013) 0.76
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response. J Neuroinflammation (2015) 0.75
Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products. Evid Based Complement Alternat Med (2015) 0.75
Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease. Rheumatol Int (2008) 0.75
Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. Rheumatol Int (2008) 0.75
Skin reaction to adalimumab. Arthritis Rheum (2004) 2.56
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol (1998) 1.56
Cytokine regulation of chondrocyte functions. J Rheumatol Suppl (1995) 1.45
ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood (1995) 1.33
Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am J Pathol (1997) 1.13
CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol (2000) 1.04
Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1. Clin Exp Immunol (1989) 1.03
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci U S A (1985) 1.02
ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood (1996) 1.02
Fate of surrogate light chains in B lineage cells. J Exp Med (1996) 0.99
Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur J Immunol (2000) 0.92
Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol (1994) 0.91
The nerve growth factor/tumor necrosis factor receptor family. J Leukoc Biol (1996) 0.88
[The North American Spine Society Lumbar Spine Outcome Assessment Instrument: translation and psychometric analysis of the German version in rehabilitation patients with chronic back pain]. Z Rheumatol (2000) 0.86
Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis. Scand J Immunol (2004) 0.85
Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. Arthritis Rheum (1998) 0.85
Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. Int Immunol (1998) 0.84
Biological agents in monotherapy for the treatment of rheumatoid arthritis. Swiss Med Wkly (2014) 0.83
Regulation of CD21 expression by DNA methylation and histone deacetylation. Int Immunol (2001) 0.81
Functional MR imaging of the cervical spine in patients with rheumatoid arthritis. Acta Radiol (1998) 0.81
The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clin Rheumatol (2014) 0.79
Predominant ankle arthropathy in hereditary haemochromatosis. Rheumatology (Oxford) (1999) 0.78
Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island. Rheumatol Int (2001) 0.78
Myositis of small foot muscles. Rheumatol Int (1998) 0.76
[Kinematic versus static MRI study of the cervical spine in patients with rheumatoid arthritis]. Rofo (1999) 0.75
[Autoantibodies and the complement system--significance for pathogenesis of rheumatoid arthritis?]. Z Rheumatol (2002) 0.75
[Immunoglobulin therapy for systemic lupus erythematosus]. Immun Infekt (1993) 0.75
[Tuberculosis and atypical mycobacterioses in HIV infection. Results from the Bonn Center 1985 to 1989]. Med Klin (Munich) (1990) 0.75
Hydrostatic pressure induces apoptosis in the human leukaemic T-cell line Jurkat via the mitochondrial pathway. Scand J Immunol (2004) 0.75
Pneumocystis carinii pleuropneumonia after aerosolized pentamidine prophylaxis. Infection (1992) 0.75
[Magnetic resonance tomography in early diagnosis of rheumatoid arthritis]. Rontgenpraxis (1997) 0.75
[42-year-old patient with fever and a palpable abdominal tumor]. Internist (Berl) (1993) 0.75
Calyculin A inhibits expression of CD8alpha but not CD4 in human peripheral blood T cells. Immunobiology (2000) 0.75